CoChat

Assessing tuberculosis control priorities in high-burden settings: a modelling approach

Open access
Vesga, Juan F, Hallett, Timothy B, Reid, Michael J A, Sachdeva, Kuldeep Singh, Rao, Raghuram, Khaparde, Sunil, Dave, Paresh, Rade, Kiran, Kamene, Maureen, Omesa, Eunice, Masini, Enos, Omale, Newton, Onyango, Elizabeth, Owiti, Philip, Karanja, Muthoni, Kiplimo, Richard, Alexandru, Sofia, Vilc, Valentina, Crudu, Valeriu, Bivol, Stela, Celan, Cristina, Arinaminpathy, Nimalan · 2019 · The Lancet Global Health
Cited by 82

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

BACKGROUND: In the context of WHO's End TB strategy, there is a need to focus future control efforts on those interventions and innovations that would be most effective in accelerating declines in tuberculosis burden. Using a modelling approach to link the tuberculosis care cascade to transmission, we aimed to identify which improvements in the cascade would yield the greatest effect on incidence and mortality. METHODS: We engaged with national tuberculosis programmes in three country settings (India, Kenya, and Moldova) as illustrative examples of settings with a large private sector (India), a high HIV burden (Kenya), and a high burden of multidrug resistance (Moldova). We collated WHO country burden estimates, routine surveillance data, and tuberculosis prevalence surveys from 2011 (for India) and 2016 (for Kenya). Linking the tuberculosis care cascade to tuberculosis transmission using a mathematical model with Bayesian melding in each setting, we examined which cascade shortfalls would have the greatest effect on incidence and mortality, and how the cascade could be used to monitor future control efforts. FINDINGS: Modelling suggests that combined measures to strengthen the care cascade could reduce cumulative tuberculosis incidence by 38% (95% Bayesian credible intervals 27-43) in India, 31% (25-41) in Kenya, and 27% (17-41) in Moldova between 2018 and 2035. For both incidence and mortality, modelling suggests that the most important cascade losses are the proportion of patients visiting the private health-care sector in India, missed diagnosis in health-care settings in Kenya, and drug sensitivity testing in Moldova. In all settings, the most influential delay is the interval before a patient's first presentation for care. In future interventions, the proportion of individuals with tuberculosis who are on high-quality treatment could offer a more robust monitoring tool than routine notifications of tuberculosis. INTERPRETATION: Linked to transmission, the care cascade can be valuable, not only for improving patient outcomes but also in identifying and monitoring programmatic priorities to reduce tuberculosis incidence and mortality. FUNDING: US Agency for International Development, Stop TB Partnership, UK Medical Research Council, and Department for International Development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2214-109x(19)30037-3

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 82

Metadata

Authors
Vesga, J. F., Hallett, T. B., Reid, M. J. A., Sachdeva, K. S., Rao, R., Khaparde, S., Dave, P., Rade, K., Kamene, M., Omesa, E., Masini, E., Omale, N., Onyango, E., Owiti, P., Karanja, M., Kiplimo, R., Alexandru, S., Vilc, V., Crudu, V., Bivol, S., Celan, C., & Arinaminpathy, N.
Venue
The Lancet Global Health
Publisher
Elsevier BV
Published
2019-05
Volume
7
Issue
5
Pages
e585-e595
ISSN
2214-109X (ISSN-L)
OpenAlex
W2923504095
Cited by
82
References
4
FWCI
8.07
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Assessing tuberculosis control priorities in high-burden settings: a modelling approach. https://app.cochat.ai/papers/10.1016/s2214-109x(19)30037-3
The paper
Vesga, J. F., Hallett, T. B., Reid, M. J. A., Sachdeva, K. S., Rao, R., Khaparde, S., Dave, P., Rade, K., Kamene, M., Omesa, E., Masini, E., Omale, N., Onyango, E., Owiti, P., Karanja, M., Kiplimo, R., Alexandru, S., Vilc, V., Crudu, V., . . . Arinaminpathy, N. (2019). Assessing tuberculosis control priorities in high-burden settings: a modelling approach. The Lancet Global Health. https://doi.org/10.1016/s2214-109x(19)30037-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.